ArticleBritish journal of clinical pharmacology2022

Tocilizumab for reduction of mortality in severe COVID-19 patients: How should we GRADE it?

Vladimir TrkuljaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.